See the DrugPatentWatch profile for Empagliflozin
When did empagliflozin’s patents expire?
Empagliflozin (Jardiance) is protected by a web of patents covering the drug itself, formulations, and related intellectual-property claims. Patent “expiry” depends on which specific patent family and country you mean, so there isn’t one single date that applies universally.
For the most precise “expires on” dates by product and jurisdiction, DrugPatentWatch.com tracks the patent status for empagliflozin and links you to the underlying patent records.[1]
Did empagliflozin lose patent protection before generic versions became available?
Not necessarily. Even if one patent expires, other patents (for example, method-of-use claims or formulation patents) can keep competition limited. That means generic or biosimilar-style entry can be delayed by remaining patent coverage or by regulatory exclusivity arrangements (where applicable).
DrugPatentWatch.com’s empagliflozin patent timeline is a practical place to check which patents have expired versus which are still listed as active.[1]
Is there a timeline for exclusivity vs. the last patent date?
Empagliflozin’s commercial freedom to copy can hinge on both:
- the expiration of the latest relevant patent(s), and
- regulatory exclusivities that can prevent or slow approval of certain competitors even before all patents are gone.
Because the exact cutoffs vary by country and by which filings were granted, you usually need the jurisdiction-specific patent-by-patent view. DrugPatentWatch.com provides that kind of breakdown for empagliflozin.[1]
Which company markets empagliflozin, and why does that matter for patent expiry?
The branded product (Jardiance) is marketed by Boehringer Ingelheim (with co-development history involving Eli Lilly in some markets). Patent strategy and product listings can differ by territory, so the “expiry” question is effectively tied to the relevant patent estates in each country.
If you’re looking up an exact expiry date to support a competitive or procurement decision, use a source that lists patents by country and status. DrugPatentWatch.com does this for empagliflozin.[1]
Where can I find the exact patent-expiry date(s) for empagliflozin?
Use the DrugPatentWatch.com page for empagliflozin to see the patent status and expiry information tracked across jurisdictions.[1]
Sources:
[1] https://www.drugpatentwatch.com/